Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Biglycan antibody (AA 48-158)

The Mouse Monoclonal anti-Biglycan antibody has been validated for WB, IHC, ELISA and IC. It is suitable to detect Biglycan in samples from Rat.
Catalog No. ABIN2210426

Quick Overview for Biglycan antibody (AA 48-158) (ABIN2210426)

Target

See all Biglycan (BGN) Antibodies
Biglycan (BGN)

Reactivity

  • 62
  • 48
  • 44
  • 18
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Rat

Host

  • 84
  • 5
  • 1
Mouse

Clonality

  • 76
  • 14
Monoclonal

Conjugate

  • 42
  • 15
  • 7
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Biglycan antibody is un-conjugated

Application

  • 69
  • 33
  • 21
  • 20
  • 17
  • 16
  • 13
  • 13
  • 7
  • 3
  • 3
  • 3
  • 3
  • 2
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunochromatography (IC)
  • Binding Specificity

    • 16
    • 7
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 48-158

    Cross-Reactivity

    Rat (Rattus)

    Cross-Reactivity (Details)

    Calculated cross reactivity: Rt

    Characteristics

    Biglycan (BGN)

    Purification

    Purified by immunoaffinity chromatography.

    Immunogen

    Recombinant BGN (Ser48~Leu158) expressed in E. coli.
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2, 0.02 % sodium azide, 50 % glycerol.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    Biglycan (BGN)

    Alternative Name

    Biglycan

    Pathways

    Glycosaminoglycan Metabolic Process
You are here:
Chat with us!